Matthew Faron, PhD

Assistant Professor

view physician profile

Locations

Pathology - Froedtert Hospital

Specialties

Microbiology

Languages

English

Education

Biography

Dr. Faron works in the clinical microbiology laboratory where he focuses on developing and managing the diagnostic research. His role is to develop industry relations, design study protocols, obtain IRB clearance and manage clinical trials. Dr. Faron also gives guidance and supports safety initiatives for the clinical laboratory.

Research Interests

Next Generation Sequencing

Evidence based medicine for infectious disease

Laboratory Automation

Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay.

(Hemken PM, Israeli E, Taylor R, Jacobson C, Datwyler M, Geissler R, Hadji A, Jeanblanc N, Pandya K, Marcinkus M, Piktel R, Bogdan MF, Rodgers M, Anderson M, Ziemann R, Tieman BC, Hawksworth D, Moore J, Otis KS, Marohnic CC, Corby J, Tu B, Lin Z, Kar A, Hartnett J, Strobel C, Gregory S, Rae T, Muerhoff AS, Brophy S, Hackett JR, Daghfal D, Faron ML, Cruz A, Mohr P, Sokoll L, Davis GJ.) Clin Chem Lab Med. 2023 Feb 20 PMID: 36799248 SCOPUS ID: 2-s2.0-85148752166 02/18/2023
Verification and Validation of Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry-Based Protocols

(Faron, M.L., Buchan, B.W., and Ledeboer, N.A..) . 02/15/2023
Multicenter Evaluation of the Cepheid Xpert GBS LB XC Test.

(Thwe PM, Faron ML, Pride DT, Cruz A, Gerstbrein D, Nahmod KA, Bigham L, Du X, Lu X, Moya S, Ren P.) J Clin Microbiol. 2022 Dec 21;60(12):e0135622 PMID: 36472424 PMCID: PMC9769564 SCOPUS ID: 2-s2.0-85144596718 12/07/2022
Real world clinical feasibility of direct-from-specimen antimicrobial susceptibility testing of clinical specimens with unknown microbial load or susceptibility.

(Chen J, Navarro E, Mesich B, Gerstbrein D, Cruz A, Faron ML, Gau V.) Sci Rep. 2022 Nov 02;12(1):18525 PMID: 36323751 PMCID: PMC9630444 SCOPUS ID: 2-s2.0-85141028925 11/04/2022
Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment.

(Shihabuddin BS, Faron ML, Relich RF, Van Heukelom P, Mayne D, Staat MA, Selvarangan R, Hueschen LA, Wolk DM, House S, Harnett G, McGann K, Steele MT, Romero JR, Arms J, Lander O, Loeffelholz M, Strouts F, Cohen D.) Diagn Microbiol Infect Dis. 2022 Oct;104(2):115764 PMID: 35917666 PMCID: PMC9271353 SCOPUS ID: 2-s2.0-85135545220 08/03/2022
Comparison of Methods for Determining the Antibiotic Susceptibility of Aerococcus Species in a Clinical Setting.

(Scholtz SL, Faron ML, Buchan BW, Ledeboer NA.) Am J Clin Pathol. 2022 May 04;157(5):781-788 PMID: 34893797 SCOPUS ID: 2-s2.0-85129998230 12/12/2021
Rapid identification from rectal swabs of the clinically most relevant carbapenemase genes from gram-negative bacteria using the BD MAX Check-Points CPO Assay.

(García-Fernández S, Simner PJ, Thomson G, Faron M, Bosboom R, van Griethuijsen A, García-Castillo M, Harris R, Ledeboer NA, Cantón R, Thomson KS.) Diagn Microbiol Infect Dis. 2022 Jan;102(1):115554 PMID: 34678712 SCOPUS ID: 2-s2.0-85117421272 10/23/2021
Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.

(Desai KT, Alfaro K, Mendoza L, Faron M, Mesich B, Maza M, Dominguez R, Valenzuela A, Acosta CD, Martínez M, Felix JC, Masch R, Smith JS, Gabrilovich S, Wu T, Plump M, Novetsky AP, Einstein MH, Douglas NC, Cremer M, Wentzensen N.) Microbiol Spectr. 2021 Oct 31;9(2):e0084621 PMID: 34668736 PMCID: PMC8528118 SCOPUS ID: 2-s2.0-85119105510 10/21/2021
A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144.

(Miller H, Simpson P, Forman M, Prigan A, Kehl S, Mesich B, Faron M, Ledeboer N, Arav-Boger R.) J Clin Microbiol. 2021 Jul 19;59(8):e0096421 PMID: 34076473 PMCID: PMC8373222 SCOPUS ID: 2-s2.0-85112127278 06/03/2021
Evaluation of a High-Definition PCR Assay for the Detection of SARS-CoV-2 in Extracted and Nonextracted Respiratory Specimens Collected in Various Transport Media.

(Buchan BW, Gerstbrein D, Cruz A, Hoff J, Sievert E, Ledeboer NA, Faron ML.) Am J Clin Pathol. 2021 Jun 17;156(1):24-33 PMID: 33940605 PMCID: PMC8135719 SCOPUS ID: 2-s2.0-85108387082 05/04/2021
Feasibility and potential significance of rapid in vitro qualitative phenotypic antimicrobial susceptibility testing of gram-negative bacilli with the ProMax system.

(Chen J, Tomasek M, Cruz A, Faron ML, Liu D, Rodgers WH, Gau V.) PLoS One. 2021;16(3):e0249203 PMID: 33770124 PMCID: PMC7996979 SCOPUS ID: 2-s2.0-85103301456 03/27/2021
Digital Image Analysis for the Detection of Group B Streptococcus from ChromID Strepto B Medium Using PhenoMatrix Algorithms.

(Baker J, Timm K, Faron M, Ledeboer N, Culbreath K.) J Clin Microbiol. 2020 Dec 17;59(1) PMID: 33087433 PMCID: PMC7771474 SCOPUS ID: 2-s2.0-85098517412 10/23/2020